Key Factors You're Ignoring When Comparing College Costs
Pssst! Have You Seen the Steals at Secondhand Stores?
How Men Buy Groceries - and How Stores Are Taking Note
Week's Winners and Losers: Apple Delights, Penney Disappoints
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.